Massachusetts H1092 aims to ensure affordable prescription medications through accountability standards.

Massachusetts H1092 mandates that pharmacy benefit managers obtain a license from the division under chapter 176O as a condition of contracting with a carrier. The bill requires manufacturers to disclose information about drug pricing, including wholesale acquisition cost increases, research and development expenditures, and factors affecting drug pricing. The Health Policy Commission reviews this information to determine if drug pricing is reasonable or excessive. If deemed unreasonable, the commission issues recommendations to reduce drug costs and improve affordability.

Massachusetts H1092 aims to ensure affordable prescription medications through accountability standards.

Massachusetts H1092 mandates that pharmacy benefit managers obtain a license from the division under chapter 176O as a condition of contracting with a carrier. The bill requires manufacturers to disclose information about drug pricing, including wholesale acquisition cost increases, research and development expenditures, and factors affecting drug pricing. The Health Policy Commission reviews this information to determine if drug pricing is reasonable or excessive. If deemed unreasonable, the commission issues recommendations to reduce drug costs and improve affordability.